We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cardiac stem cell therapies inch toward clinical litmus test.
- Authors
Sheridan, Cormac
- Abstract
The article offers information about stem cell therapies for cardiac diseases. It informs that Cardio3 BioSciences SA and Mesoblast Ltd. have started phase 3 trials of bone marrow in congestive heart failure which is derived from mesenchymal cell therapies. A table is presented containing several companies including Osiris TherapeuticsInc., Aastrom Biosciences Inc. and Amorcyte which provide adult stem cell therapies in efficacy trials.
- Subjects
CARDIO3 BioSciences SA; VERICEL Corp.; MESOBLAST Ltd.; STEM cell treatment; BONE marrow; HEART diseases; CHARTS, diagrams, etc.
- Publication
Nature Biotechnology, 2013, Vol 31, Issue 1, p5
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0113-5